Top obesity research from ENDO 2016

Researchers presented data and clinical updates at ENDO 2016, the Endocrine Society's 98th Annual Meeting & Expo. Live coverage from Boston featured news from the conference, onsite video interviews with leading experts and research implications on patient care and practice.

Healio Internal Medicine presents the top seven obesity stories from ENDO 2016.

Adults with large, early weight loss least likely to regain weight

Adults with obesity who reduced their BMI by 15% or more during a 6-month period were more likely to continue to lose weight and less likely to experience weight cycling vs. those who lost less weight, according to study findings. Read more.

Intensive lifestyle intervention improves cardiometabolic profile, bone quality in older adults with type 2 diabetes

Older adults with overweight or obesity and type 2 diabetes saw improved glucose control, body composition, physical function and bone quality when assigned to an intensive diet and exercise training program, according to preliminary results from an ongoing randomized trial. Read more.

Lower indoor temperature in winter linked to lower waist measurement

Older adults exposed to colder in-home temperature during winter months have a lower average waist circumference than adults with a warmer indoor temperature, according to study findings. Read more.

Liraglutide reduces type 2 diabetes risk in adults with prediabetes, obesity

More than half of adults with prediabetes and overweight or obesity randomly assigned liraglutide returned to normoglycemia at 3 years, improving their cardiometabolic profile and reducing their risk for developing type 2 diabetes, according to study findings. Read more.

Testosterone therapy plus very low calorie diet prevents lean mass loss in men

Healthy men with obesity and low testosterone randomly assigned testosterone therapy combined with a very low calorie diet maintained their muscle mass while losing body fat, whereas men assigned placebo lost both lean and fat mass, according to study findings. Read more.

EHR data: 1% of eligible patients use weight loss drugs

Prescribing rates for weight-loss drugs to treat obesity remain low, with just 1% of eligible patients using pharmacologic treatment options and “tremendous variability” in provider prescribing rates, according to an analysis of electronic health records. Read more.

PCOS, overweight, obesity increase risk for asthma

Independent associations were found between asthma and polycystic ovary syndrome as well as overweight and obesity, according to study results. Read more.